Lindab Group’s full year report January-December 2025: Strengthened profitability for Ventilation Systems

Lindab reported FY 2025 sales of SEK 12,854m (‑4% YoY) with adjusted operating profit SEK 1,027m and an adjusted operating margin of 8.0% (7.8), while operating profit rose to SEK 1,097m driven by SEK 70m of one‑off items; profit for the year was SEK 760m and EPS SEK 9.86, and the Board proposes a SEK 5.60 dividend. In Q4 net sales were SEK 3,134m (‑5%), adjusted operating profit improved to SEK 203m and adjusted margin to 6.5%, despite negative currency effects (‑4% Q4, ‑3% FY) and ongoing restructuring (Q4 one‑offs SEK ‑106m); Ventilation Systems (80% of sales) showed organic growth and margin improvement while Profile Systems remained weak and subject to divestments in Eastern Europe. Management flagged continued efficiency measures, automated production investments and a cautiously improved market outlook for 2026, positioning the group for moderate earnings stability but leaving execution and regional demand (notably Germany) as key risks.

Analysis

Market structure: Lindab (LIAB) benefits as a pure-play ventilation consolidator — Ventilation Systems (80% of sales) should capture share as weaker, undisciplined regional competitors exit Eastern Europe; Profile Systems shrinkage transfers customer volumes to builders’ merchants and larger HVAC OEMs. Pricing power is moderate: product commoditization limits pass-through, but automation and procurement synergies can raise adjusted margins toward 9%–10% if volumes stabilize (+2–4% organic). Cross-asset: a credible margin re-rating would tighten corporate credit spreads for LIAB, reduce implied equity volatility, and modestly strengthen SEK vs. peers via FX flows in Scandinavia.

Risk assessment: Primary tail risks are a prolonged German construction slump (volumes down >10% year-on-year), adverse FX moves (SEK weakening >5% vs. EUR), or a failed integration/automation ramp causing capex overruns. Immediate catalysts are the Feb 12 webcast and the proposed dividend (SEK 5.60); near-term (Q1 2026) trigger is Romania divestment closing; long-term (through 2028–2030) execution risk lies in M&A integration and sustaining organic growth. Hidden dependency: margin expansion assumes procurement synergies and higher volumes; if volumes stay flat, margin gains may be one-off.

Trade implications: Constructive on LIAB vs. peers — establish a modest long (2–3% portfolio) ahead of Q1 2026 catalysts, target 12–18% upside in 6–12 months if adjusted margin >8.5% and organic growth turns positive. Pair trade idea: long LIAB / short Systemair (SYSR B) to capture relative operational leverage; use size-adjusted beta weighting and 6–12 month horizon. Options: prefer a 9–12 month bullish call spread (buy 25% OTM, sell 50% OTM) sized 0.5–1% portfolio to cap premium.

Contrarian angles: Consensus focuses on flat sales; it underestimates structural margin upside from automation and portfolio pruning — if Lindab converts 50–70% of restructuring savings to EBITDA, EPS could double from 2025 levels by 2027. Beware overextension: a premature M&A push or mis-timed production capacity build before demand recovery would reverse gains. Watch for five benchmarks: organic growth >+2% (positive), adjusted margin >9% (re-rate), Germany volumes falling >10% (negative), Romania divestment failure (negative), and net leverage moving >2.0x EBITDA (risk signal).

Key Decisions for Investors

• Establish a 2–3% long position in Lindab Group (Nasdaq Stockholm: LIAB) within 2 weeks, targeting 12–18% upside over 6–12 months if adjusted operating margin stays >=8.5% and organic growth turns positive; cut to flat if price falls 8% from entry.
• Implement a relative value pair trade: go long LIAB (1.5% portfolio) and short Systemair (SYSR B) (1.0% portfolio), sized by beta, 6–12 month horizon — thesis: Lindab’s restructuring and divestments drive superior margin expansion vs. peer.
• Buy a 9–12 month LIAB call spread (buy 25% OTM, sell 50% OTM) sized 0.5–1.0% portfolio to lever upside around Q1 2026 divestment close and H2 2026 ventilation recovery; max loss = premium, pick strikes if implied vol is below 30%.
• If dividend yield >4% on announcement/ex-div date, consider a short-term dividend capture: buy LIAB 5–7 trading days before ex-div and sell 3–5 days after, but only if market bid-ask and borrow costs are low; avoid if liquidity/borrow costs exceed 50 bps.